Warning letter
Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center: warning letter of Apr 4, 2018
FDA warning letter 552431 · Los Angeles District Office
Key facts
| Reference number | 552431 |
|---|---|
| Company | Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center |
| Subject | Drug Product/Adulterated |
| Issue date | Apr 4, 2018 |
| Posted date | Apr 17, 2018 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| Inspection city | Federal Way |
| Inspection ZIP | 98003 |
| Inspection start date | Jan 26, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: